Innospec Inc. (NASDAQ:IOSP) Shares Sold by Arizona State Retirement System

Arizona State Retirement System reduced its position in Innospec Inc. (NASDAQ:IOSPFree Report) by 1.8% in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 6,952 shares of the specialty chemicals company’s stock after selling 129 shares during the quarter. Arizona State Retirement System’s holdings in Innospec were worth $857,000 at the end of the most recent reporting period.

Other hedge funds have also recently added to or reduced their stakes in the company. Belpointe Asset Management LLC grew its holdings in Innospec by 226.2% in the 1st quarter. Belpointe Asset Management LLC now owns 274 shares of the specialty chemicals company’s stock valued at $28,000 after buying an additional 190 shares in the last quarter. Captrust Financial Advisors grew its holdings in Innospec by 74.7% in the 1st quarter. Captrust Financial Advisors now owns 498 shares of the specialty chemicals company’s stock valued at $46,000 after buying an additional 213 shares in the last quarter. Point72 Hong Kong Ltd purchased a new stake in Innospec in the 1st quarter valued at $53,000. Point72 Middle East FZE purchased a new stake in Innospec in the 4th quarter valued at $57,000. Finally, UBS Group AG grew its holdings in Innospec by 71.6% in the 3rd quarter. UBS Group AG now owns 1,009 shares of the specialty chemicals company’s stock valued at $86,000 after buying an additional 421 shares in the last quarter. 96.64% of the stock is owned by institutional investors and hedge funds.

Innospec Stock Down 0.4 %

Shares of NASDAQ:IOSP opened at $120.52 on Thursday. The business has a fifty day moving average of $124.17 and a two-hundred day moving average of $115.00. The stock has a market cap of $3.01 billion, a P/E ratio of 21.64 and a beta of 1.10. Innospec Inc. has a 52-week low of $91.74 and a 52-week high of $131.18.

Innospec (NASDAQ:IOSPGet Free Report) last issued its earnings results on Tuesday, February 13th. The specialty chemicals company reported $1.84 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.59 by $0.25. The company had revenue of $494.70 million during the quarter, compared to analysts’ expectations of $479.47 million. Innospec had a return on equity of 13.69% and a net margin of 7.14%. The firm’s quarterly revenue was down 3.1% on a year-over-year basis. During the same period in the prior year, the business earned $1.20 EPS. On average, equities analysts anticipate that Innospec Inc. will post 6.72 earnings per share for the current year.

Insider Transactions at Innospec

In other news, SVP David B. Jones sold 2,500 shares of the stock in a transaction on Friday, March 1st. The stock was sold at an average price of $125.79, for a total transaction of $314,475.00. Following the completion of the transaction, the senior vice president now directly owns 9,664 shares in the company, valued at approximately $1,215,634.56. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. In other news, CEO Patrick Williams sold 9,667 shares of the stock in a transaction on Friday, February 23rd. The stock was sold at an average price of $124.37, for a total transaction of $1,202,284.79. Following the completion of the transaction, the chief executive officer now directly owns 174,334 shares in the company, valued at approximately $21,681,919.58. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, SVP David B. Jones sold 2,500 shares of the stock in a transaction on Friday, March 1st. The stock was sold at an average price of $125.79, for a total value of $314,475.00. Following the transaction, the senior vice president now owns 9,664 shares of the company’s stock, valued at $1,215,634.56. The disclosure for this sale can be found here. In the last ninety days, insiders sold 36,500 shares of company stock worth $4,532,959. 1.35% of the stock is currently owned by company insiders.

Innospec Company Profile

(Free Report)

Innospec Inc develops, manufactures, blends, markets, and supplies specialty chemicals in the United States, rest of North America, the United Kingdom, rest of Europe, and internationally. The company's Fuel Specialties segment offers a range of specialty chemical products that are used as additives in additives in diesel, jet, marine, fuel oil and other fuels.

Read More

Want to see what other hedge funds are holding IOSP? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Innospec Inc. (NASDAQ:IOSPFree Report).

Institutional Ownership by Quarter for Innospec (NASDAQ:IOSP)

Receive News & Ratings for Innospec Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Innospec and related companies with MarketBeat.com's FREE daily email newsletter.